Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short‐term intensive insulin therapy for type 2 diabetes

Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short‐term intensive insulin therapy for type 2 diabetes

Abstract Background Extrachromosomal circular DNA (eccDNA) has emerged as a promising biomarker for disease diagnosis and prognosis prediction. However, its role in type 2 diabetes remains unexplored. Objective To investigate the characteristics and dynamics of circulating eccDNAs in newly diagnosed...

Full description

Bibliographic Details
Main Authors: Zhe Xu, Junyu He, Peng Han, Peiji Dai, Wei Lv, Nian Liu, Liyi Liu, Liehua Liu, Xiaoguang Pan, Xi Xiang, Hanbo Li, Fangfang Ge, Shan Gao, Zhihong Liao, Yonglun Luo, Yanbing Li
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Clinical and Translational Medicine
Subjects:
diabetes
extrachromosomal circular DNA
short‐term intensive insulin therapy
Online Access:https://doi.org/10.1002/ctm2.1437

Internet

https://doi.org/10.1002/ctm2.1437

Similar Items